KaloBios fires Shkreli, embattled pharmaceutical executive reviled for price hikes

TRENTON, N.J. -- In barely 24 hours, Martin Shkreli went from an egotistical pharmaceutical boy wonder running two small drug developers and live-streaming his daily activities to unemployed and facing securities fraud charges that could land him in prison for years.

See Full Article

Shkreli, already reviled by the public for astronomical price gouging on a life-saving drug, was terminated by KaloBios Pharmaceuticals, the company disclosed Monday.

The South San Francisco, California, company said in a statement that it terminated Shkreli as its CEO last Thursday and that he resigned from its board of directors then. That was the same day that Shkreli, a 32-year-old former hedge fund manager, was arrested in New York and charged with securities fraud and conspiracy related to a company he previously ran.

Shkreli was led from his apartment in handcuffs by authorities Thursday morning and later pleaded not guilty and was released on $5 million bail. The charges carry a sentence of up to 20 years in prison if he's convicted. By the time Shkreli made bail, Turing Pharmaceuticals Inc., which he had founded and ran, announced he had resigned as the CEO.

It was a surprising reversal, even for an executive dubbed the "most hated man in America" this fall after he jacked up the price of Daraprim from $13.50 to $750 per pill. Daraprim is the only approved drug for a life-threatening parasitic infection that mainly strikes pregnant women, cancer patients and AIDS patients.

Amid mounting criticism from patients, doctors and politicians, Shkreli pledged to lower Daraprim's price, but later reneged and instead offered hospitals a 50 per cent discount -- still amounting to a 2,500 per cent increase. Patients normally take most of the weeklong treatment at home, so they still face the 5,000 per cent price increase, though Turing is offering financial aid to those who can't afford the drug.

Shkreli has since said that law enforcement targeted him because of the price hike.

Meanwhile, Shkreli's Twitter account was hacked Sunday. Posts including "I am now a god," "Anyone want free money? Willing to donate hundreds of thousands to charities before I go to prison ..." and numerous unprintable ones accumulated on the page before he regained control and deleted them. Many are still viewable on Twitter under "martin shkreli hacked."

His You Tube account, where he's frequently live-streamed himself working on his home computer, talking to himself and eating, also was hit with posts belittling him and hasn't been active since Sunday.

KaloBios Pharmaceuticals Inc. is a faltering drug company whose shares skyrocketed after Nov. 19, when Martin Shkreli disclosed a huge stake and became its CEO and board chairman. At the same time, a few people resigned from the company's board of directors and were replaced by three new people. One of them, Tony Chase, resigned from that position last Thursday when Shkreli was ousted.

Trading in KaloBios shares has been halted since Thursday. The company wouldn't answer questions Monday about who will take control and when its shares will resume trading.

It has been attempting to develop drugs to treat cancer and leukemia. Its shares tumbled 70 per cent in January after its drug for lung infections failed in testing. The company announced it would shut down right before Shkreli and a group of investors swooped in with cash and pledges of financing to keep it going.

Federal prosecutors allege that from 2009 to 2014, Shkreli made bad trades that lost money of some investors in his hedge fund, MSMB Capital Management, then looted a pharmaceutical company called Retrophin, where he was then CEO, for $11 million to pay back his disgruntled clients.

On Saturday, Shkreli tweeted: "I am confident I will prevail."



Advertisements

Latest Economic News

  • Unifor says it has left Canadian Labour Congress over dispute

    Economic CBC News
    ?Unifor, the largest private sector union in Canada, says it is splitting with the Canadian Labour Congress over disagreements about the rights of workers to choose which union should represent them. In a letter to the CLC, Unifor national president Jerry Dias and Quebec director Renaud Gagne say the congress has been less than supportive of its concern about American-based unions "trampling on the rights" of workers and their right to choose representation or express dissent. Source
  • Bread price-fixing documents won't be unsealed Thursday, Loblaw says

    Economic CTV News
    BRAMPTON, Ont. -- Loblaw says court documents regarding an alleged industry-wide bread price-fixing scheme won't be released tomorrow after an unidentified individual filed an application against releasing them. The information to obtain, which outlines why the Competition Bureau wanted search warrants in the case against at least seven companies, including Canada's three major grocers, has been sealed for 30 days and was scheduled to be released Thursday morning. Source
  • Home Capital vows to defend itself against short seller's $4M lawsuit

    Economic CTV News
    TORONTO -- Home Capital Group (TSX:HCG) says it vows to defend itself against misrepresentation claims in a $4-million lawsuit filed by a short seller against the alternative lender and three of its former executives. The company issued a response after California-based short seller Marc Cohodes on Monday filed a statement of claim with the Ontario Superior Court of Justice, alleging that the company's misrepresentations in its financial reporting cost him millions when he closed his position…
  • Home Capital vows to defend itself against short seller's lawsuit

    Economic CBC News
    Home Capital Group days it vows to defend itself against misrepresentation claims in a $4-million lawsuit filed by a short seller against the alternative lender and three of its former executives. The company issued a response after California-based short seller Marc Cohodes on Monday filed a statement of claim with the Ontario Superior Court of Justice, alleging that the company's misrepresentations in its financial reporting cost him millions when he closed his position early. Source
  • Canada's new distillery district? Nova Scotia sees explosion in craft spirits

    Economic CTV News
    HALIFAX -- Nova Scotia has kindled an explosion of spirit makers -- there are now 16 in Canada's second-smallest province -- through attractive craft-distillery policies and collaborations with local farmers. The Nova Scotia Liquor Corporation says 12 of those distilleries have popped up in the last five years, serving rum, gin, vodka and other spirits. Source
  • Loblaw, CRA face off in court in dispute that could cost grocery giant $404M

    Economic CTV News
    TORONTO -- Loblaw Companies Ltd. and the Canada Revenue Agency faced off in a Toronto court Wednesday in a $404-million dispute involving allegations that the grocery giant's Barbadian banking subsidiary was misused for tax avoidance. Source
  • Fed survey finds solid U.S. growth and rising wages

    Economic CTV News
    WASHINGTON -- The Federal Reserve reported Wednesday that the economy was growing at a moderate pace at the start of the year, with the majority of business contacts optimistic about prospects for 2018. In its latest survey of business conditions nationwide, the Fed said that wages were rising at a modest pace. Source
  • Bombardier won't confirm pending order in Iran for 10 regional jets

    Economic CTV News
    MONTREAL -- Bombardier Inc. will not confirm a published report in Iran that the Canadian planemaker is finalizing its first commercial aircraft order in the Middle Eastern country. The Quebec-based company has acknowledged in the past that it was exploring opportunities in Iran. Source
  • Royal Bank raises prime lending rate to 3.45% in wake of Bank of Canada decision

    Economic CTV News
    TORONTO -- The Royal Bank of Canada (TSX:RY) is raising its prime lending rate by a quarter of a percentage point in the wake of the Bank of Canada's decision to raise its key interest rate target. Source
  • Canadian banks raise prime lending rate to 3.45% in wake of Bank of Canada move

    Economic CTV News
    TORONTO -- Canada's biggest banks will hike their prime rate by a quarter of a percentage point on Thursday, putting financial pressure on homeowners with variable rate mortgages. The Royal Bank of Canada (TSX:RY) was first to announce its prime rate will rise to 3.45 per cent, shortly after the Bank of Canada raised its key short-term rate by a quarter-point to 1.25 per cent. Source